Investigation of Choice for Takotsubo Cardiomyopathy
Coronary angiography (CAG) with left ventriculography is the investigation of choice for Takotsubo cardiomyopathy in the acute setting, as it is essential to exclude acute coronary syndrome and confirm the diagnosis by demonstrating absence of obstructive coronary disease with characteristic regional wall motion abnormalities extending beyond a single coronary territory 1.
Acute Phase Diagnostic Approach
Primary Investigation: Coronary Angiography
In the acute presentation, when patients present with chest pain, ST-elevation, and elevated cardiac biomarkers mimicking acute myocardial infarction, final differential diagnosis from ACS requires coronary angiography 1. This is typically performed in the context of primary PCI services for ST-elevation presentations.
Key elements to assess during CAG:
- Absence of obstructive coronary artery disease (or perfusion-contraction mismatch if CAD present)
- Biplane ventriculography to identify characteristic ballooning patterns
- Hemodynamic assessment for left ventricular outflow tract obstruction (present in ~20% of cases)
- Left ventricular end-diastolic pressure measurement 1
Initial Bedside Investigation: Echocardiography
Echocardiography is the most used imaging tool to rapidly assess regional wall motion abnormalities at the bedside 1. It identifies:
- Symmetric regional wall motion abnormalities extending beyond single coronary territory
- Wall motion score index ≥1.75 with >4 dysfunctional segments (83% sensitivity, 100% specificity) 1
- LV outflow tract obstruction and mitral regurgitation
- Apical ballooning, midventricular, basal, or focal variants 1, 2
Critical pitfall: Echocardiography alone cannot definitively exclude ACS—coronary angiography remains mandatory for diagnosis.
Subacute Phase: Cardiac MRI for Definitive Characterization
Cardiac MRI (CMR) cannot be used easily in the acute setting but is very useful in the subacute phase 1. CMR provides incremental diagnostic value through:
Diagnostic CMR Criteria for TTS:
- Typical regional wall motion abnormalities
- Myocardial edema in dysfunctional segments
- Absence of late gadolinium enhancement (LGE) in dysfunctional regions—this is the key distinguishing feature 1
CMR's superior diagnostic capability:
- Distinguishes TTS from ACS (which shows subendocardial/transmural LGE in vascular territory) 1
- Distinguishes from myocarditis (which shows epicardial or patchy LGE) 1
- Superior to echo for detecting right ventricular involvement 1
- Detects complications: LV/RV thrombi, pericardial effusion 1
Alternative Non-Invasive Approach: Cardiac CT Angiography
CCTA may be an appropriate alternative to CAG in specific high-risk scenarios 1:
- Life-threatening comorbidities (terminal malignancy, intracranial bleeding, bleeding diathesis)
- Advanced age with frailty
- Stable patients with low ACS suspicion
- Suspected recurrent TTS with previous CAG
- Acute critical illnesses (sepsis, subarachnoid hemorrhage, stroke) with biomarker elevation 1
Limitation: CCTA requires higher radiation exposure for cardiac cycle imaging to assess wall motion 1.
Nuclear Imaging: Research Role Only
Cardiac nuclear imaging (SPECT, PET) with perfusion, metabolic, and sympathetic innervation tracers has been used primarily for research purposes to investigate TTS pathophysiology, not for routine clinical diagnosis 1.
Algorithmic Approach
Acute presentation (chest pain, ST-elevation, troponin elevation):
- Immediate echocardiography → identify wall motion abnormalities
- Coronary angiography with ventriculography → exclude ACS, confirm diagnosis
- Assess for LVOTO during catheterization
Subacute phase (3-7 days post-presentation):
- Cardiac MRI → confirm diagnosis, exclude differential diagnoses, assess for complications
High-risk patients where CAG poses excessive risk:
- Cardiac CT angiography → assess coronary anatomy and wall motion
Common pitfall: Approximately one-third of TTS patients have coexisting significant CAD 1. In these cases, careful comparison of CAG and biplane ventriculography is mandatory to identify perfusion-contraction mismatch—the hallmark being wall motion abnormalities extending beyond the territory of the stenotic vessel.